Literature DB >> 28455696

Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities.

Alexios-Fotios A Mentis1,2, Efthimios Dardiotis3, Nikolaos Grigoriadis4, Efthimia Petinaki5, Georgios M Hadjigeorgiou3.   

Abstract

Viruses are directly or indirectly implicated in multiple sclerosis (MS). Here, we review the evidence on the virus-related pathophysiology of MS, introduce common experimental models, and explore the ways in which viruses cause demyelination. By emphasizing knowledge gaps, we highlight future research directions for effective MS diagnostics and therapies: (i) identifying biomarkers for at-risk individuals, (ii) searching for direct evidence of specific causative viruses, (iii) establishing the contribution of host genetic factors and viruses, and (iv) investigating the contribution of immune regulation at extra-CNS sites. Research in these areas is likely to be facilitated by the application of high-throughput technologies, the development of systems-based bioinformatic approaches, careful selection of experimental models, and the acquisition of high-quality clinical material for tissue-based research.

Entities:  

Keywords:  Bystander activation; Epitope spreading; Molecular mimicry; Multiple sclerosis; Sequencing; Virus

Mesh:

Year:  2017        PMID: 28455696     DOI: 10.1007/s12035-017-0530-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  114 in total

1.  Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway.

Authors:  Spyridon Stavrou; Zongdi Feng; Stanley M Lemon; Raymond P Roos
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

2.  Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

Authors:  Eileen J McMahon; Samantha L Bailey; Carol Vanderlugt Castenada; Hanspeter Waldner; Stephen D Miller
Journal:  Nat Med       Date:  2005-02-27       Impact factor: 53.440

Review 3.  Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses.

Authors:  Lazaros Belbasis; Vanesa Bellou; Evangelos Evangelou; John P A Ioannidis; Ioanna Tzoulaki
Journal:  Lancet Neurol       Date:  2015-02-04       Impact factor: 44.182

4.  Opportunistic DNA Recombination With Epstein-Barr Virus at Sites of Control Region Rearrangements Mediating JC Virus Neurovirulence.

Authors:  Margaret J Wortman; Patric S Lundberg; Ayuna V Dagdanova; Pranav Venkataraman; Dianne C Daniel; Edward M Johnson
Journal:  J Infect Dis       Date:  2015-12-21       Impact factor: 5.226

5.  Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.

Authors:  Gurumoorthy Krishnamoorthy; Hans Lassmann; Hartmut Wekerle; Andreas Holz
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

6.  Mechanisms of primary axonal damage in a viral model of multiple sclerosis.

Authors:  Jayasri Das Sarma; Lawrence C Kenyon; Susan T Hingley; Kenneth S Shindler
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

Review 7.  Multiple sclerosis - a response-to-damage model.

Authors:  Bert A 't Hart; Rogier Q Hintzen; Jon D Laman
Journal:  Trends Mol Med       Date:  2009-05-18       Impact factor: 11.951

8.  Demyelination in a transgenic mouse: a model for multiple sclerosis.

Authors:  F G Mastronardi; C A Ackerley; L Arsenault; B I Roots; M A Moscarello
Journal:  J Neurosci Res       Date:  1993-10-15       Impact factor: 4.164

9.  B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.

Authors:  Joel N H Stern; Gur Yaari; Jason A Vander Heiden; George Church; William F Donahue; Rogier Q Hintzen; Anita J Huttner; Jon D Laman; Rashed M Nagra; Alyssa Nylander; David Pitt; Sriram Ramanan; Bilal A Siddiqui; Francois Vigneault; Steven H Kleinstein; David A Hafler; Kevin C O'Connor
Journal:  Sci Transl Med       Date:  2014-08-06       Impact factor: 17.956

10.  Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help.

Authors:  Norifumi Iijima; Akiko Iwasaki
Journal:  Nature       Date:  2016-05-18       Impact factor: 49.962

View more
  11 in total

1.  Replication study of GWAS risk loci in Greek multiple sclerosis patients.

Authors:  Georgios M Hadjigeorgiou; Persia-Maria Kountra; Georgios Koutsis; Vana Tsimourtou; Vasileios Siokas; Maria Dardioti; Dimitrios Rikos; Chrysoula Marogianni; Athina-Maria Aloizou; Georgia Karadima; Styliani Ralli; Nikolaos Grigoriadis; Dimitrios Bogdanos; Marios Panas; Efthimios Dardiotis
Journal:  Neurol Sci       Date:  2018-10-26       Impact factor: 3.307

2.  CpG Island Methylation Patterns in Relapsing-Remitting Multiple Sclerosis.

Authors:  Maria Sokratous; Efthimios Dardiotis; Eleni Bellou; Zisis Tsouris; Amalia Michalopoulou; Maria Dardioti; Vasileios Siokas; Dimitrios Rikos; Aristidis Tsatsakis; Leda Kovatsi; Dimitrios P Bogdanos; Georgios M Hadjigeorgiou
Journal:  J Mol Neurosci       Date:  2018-03-07       Impact factor: 3.444

Review 3.  Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System.

Authors:  Maria Lima; Vasileios Siokas; Athina-Maria Aloizou; Ioannis Liampas; Alexios-Fotios A Mentis; Zisis Tsouris; Anastasios Papadimitriou; Panayiotis D Mitsias; Aristidis Tsatsakis; Dimitrios P Bogdanos; Stavros J Baloyannis; Efthimios Dardiotis
Journal:  Curr Treat Options Neurol       Date:  2020-09-25       Impact factor: 3.598

Review 4.  Body mass index and survival from amyotrophic lateral sclerosis: A meta-analysis.

Authors:  Efthimios Dardiotis; Vasileios Siokas; Maria Sokratous; Zisis Tsouris; Athina-Maria Aloizou; Desponia Florou; Metaxia Dastamani; Alexios-Fotios A Mentis; Alexandros G Brotis
Journal:  Neurol Clin Pract       Date:  2018-10

Review 5.  [The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].

Authors:  Tobias Monschein; Tobias Zrzavy; Micha Löbermann; Alexander Winkelmann; Thomas Berger; Paulus Rommer; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nervenarzt       Date:  2021-07-07       Impact factor: 1.297

6.  Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis.

Authors:  Elin Engdahl; Rasmus Gustafsson; Jesse Huang; Martin Biström; Izaura Lima Bomfim; Pernilla Stridh; Mohsen Khademi; Nicole Brenner; Julia Butt; Angelika Michel; Daniel Jons; Maria Hortlund; Lucia Alonso-Magdalena; Anna Karin Hedström; Louis Flamand; Masaru Ihira; Tetsushi Yoshikawa; Oluf Andersen; Jan Hillert; Lars Alfredsson; Tim Waterboer; Peter Sundström; Tomas Olsson; Ingrid Kockum; Anna Fogdell-Hahn
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

7.  Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; Vasiliki Efthymiou; George P Chrousos
Journal:  BMC Med       Date:  2021-01-13       Impact factor: 8.775

Review 8.  Epstein-Barr Virus and Multiple Sclerosis.

Authors:  Gunnar Houen; Nicole Hartwig Trier; Jette Lautrup Frederiksen
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

Review 9.  Microbiome in Multiple Sclerosis; Where Are We, What We Know and Do Not Know.

Authors:  Marina Kleopatra Boziki; Evangelia Kesidou; Paschalis Theotokis; Alexios-Fotios A Mentis; Eleni Karafoulidou; Mikhail Melnikov; Anastasia Sviridova; Vladimir Rogovski; Alexey Boyko; Nikolaos Grigoriadis
Journal:  Brain Sci       Date:  2020-04-14

Review 10.  Apolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; George P Chrousos
Journal:  Mol Psychiatry       Date:  2020-04-30       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.